Login / Signup

Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.

Ambarish PandeyAhmed A KolkailahFrancesco CosentinoChristopher P CannonRobert C FrederichDavid Z I CherneySamuel Dagogo-JackRichard E PratleyNilo B CaterIra GantzJames P MancusoDarren K McGuire
Published in: European heart journal (2023)
Keyphrases
  • ejection fraction
  • heart failure
  • phase iii
  • study protocol
  • aortic stenosis
  • phase ii
  • clinical trial
  • randomized controlled trial
  • open label
  • atrial fibrillation
  • coronary artery disease